DS
Dev Sehgal
About Dev Sehgal
Data last updated:
Dev Sehgal is a Director at Canadian Remedies Medicare Private Limited (since 2017). The companies operate in Pharma. Canadian Remedies Medicare Private Limited reported revenue of ₹2.45 Cr (FY 2020). Earlier, Dev Sehgal was a Director at Genex Pharmaceutical Private Limited (2016–2022).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Canadian Remedies Medicare Private Limited U85100HR2013PTC050069 | Director | 08 Feb 2017 | 2013 | ₹2.45 Cr (FY 2020) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Genex Pharmaceutical Private Limited U33208HR2016PTC063916 | Director | 03 May 2016 | 2016 | ₹15.5 Lakh (FY 2017) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Dev Sehgal
| Name | DIN | Company | Designation |
|---|---|---|---|
| Pooja Sehgal | 09504433 | Canadian Remedies Medicare Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Dev Sehgal
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Dev Sehgal
Dev Sehgal currently holds 1 directorship: Canadian Remedies Medicare Private Limited (Director, since 08 Feb 2017, revenue ₹2.45 Cr (FY 2020)).
Dev Sehgal was first appointed on 03 May 2016 as Director at Genex Pharmaceutical Private Limited. The most recent appointment on record is 08 Feb 2017 at Canadian Remedies Medicare Private Limited.
Dev Sehgal held 1 earlier board appointment: Genex Pharmaceutical Private Limited (Director, 03 May 2016 to 21 Jul 2022).
The current boards of Dev Sehgal's companies include Pooja Sehgal (Canadian Remedies Medicare Private Limited).